VERADIGM INC (MDRX)
(Delayed Data from OTC)
$9.70 USD
+0.10 (1.04%)
Updated Jun 4, 2024 11:01 AM ET
3-Hold of 5 3
B Value C Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Veradigm Inc. [MDRX]
Reports for Purchase
Showing records 21 - 40 ( 600 total )
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Optimized Entry and Exit Levels for MDRX 10123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Optimized Entry and Exit Levels for MDRX 92123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Expects to File 10-Ks 10-Qs in 4Q23; Reduced Revenue Impact and Provided Adj. EBITDA Guidance in Line
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Optimized Entry and Exit Levels for MDRX 91123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Optimized Entry and Exit Levels for MDRX 9123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Optimized Entry and Exit Levels for MDRX 82123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Optimized Entry and Exit Levels for MDRX 81123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Update on Filing 10-K: Still on Track for Sept 18 with No Additional Revenue Findings to $40 Million Revenue Impact
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Company: Veradigm Inc.
Industry: Medical Info Systems
Optimized Entry and Exit Levels for MDRX 8123
Provider: Stock Traders Daily
Analyst: Research Department